Acadia Pharmaceuticals Inc. was downgraded after a drug setback, but strong sales and a robust pipeline offer investment ...

During year 6 of continuous treatment with BRIUMVI the annualized relapse rate was 0.012, equivalent to one relapse occurring every 83 years of patient treatment Overall safety profile of BRIUMVI rema ...

Jazz Pharmaceuticals' growth is anchored by Xywav and Epidiolex, both generating robust sales and supporting future oncology ...

UEC Breakthrough Year Transitioning to Uranium Production in Wyoming, Burke Hollow Nearing Start-Up in Texas, and the Launch of U.S. Uranium Refining & Conversion Corp Creates ...

Kingspan shares soared on Tuesday as the insulation manufacturer said it is considering floating its advanced building ...

Icotrokinra demonstrated superior skin clearance at Weeks 16 and 24 compared to deucravacitinib and similar adverse event ...

Akeso Inc. (9926.HK) is excited to announce that the Late-Breaking Abstract (LBA) from the registrational Phase III clinical ...

Results from OVATION 2 Study reinforce IMNN-001 efficacy benefits observed in the clinic and unique mechanism of action, producing key anti-cancer immune cytokines post-treatment ...

Whatever the name, the ‘A90’ (actually ‘J29,’ complementing the Z4’s ‘G29’ chassis code) Supra is a sharply responsive sporting joy. Appropriately powered, exciting even around town, and at last ...

HighTide Therapeutics, Inc. (2511.HK), a clinical stage biopharmaceutical company specializing in the development of ...